Skip to content

BioNTech Investor Relations company blog

Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Vaccine Candidate

investors.biontech.de

Read on investors.biontech.de → Discuss on HN (171) Archived copy

Points: 264
HN comments: 171
Submissions: 1
Cited by: 0 commenters

Science & Space Tech Industry & Business 2020

On Hacker News

Submitted	Title on HN	Points	Comments
Nov 18, 2020	Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Vaccine Candidate by doener	264	171

More from BioNTech Investor Relations

All 4 posts →

BioNTech presents positive phase 1/2 data for CAR-T cell therapy candidate

2023232 points95 comments Science & Space details

BioNTech-InstaDeep Early Warning System to Detect High-Risk SARS-CoV-2 Variants

2022149 points64 comments AI & Machine Learning details

BioNTech Plans to Address Infectious Diseases on the African Continent

2021103 points6 comments Science & Space details

Related posts from the same era

Gears

Bartosz Ciechanowski20202,760 points227 commentscited by 11 details

Internal Combustion Engine

Bartosz Ciechanowski20212,333 points498 commentscited by 16 details

Cameras and Lenses

Bartosz Ciechanowski20202,132 points269 commentscited by 10 details

AlphaFold: a solution to a 50-year-old grand challenge in biology

DeepMind Blog20201,473 points661 commentscited by 11 details

Hundreds of fishing vessels vanishing along Argentina’s waters

Oceana20211,210 points592 comments details

Time flies in Google Earth’s biggest update in years

Google – The Keyword20211,209 points415 comments details